Skip to main content
Signal8
Chaudhuri Sarbani profile photo

Sarbani Chaudhuri

CIK: 0002064940

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROCKET PHARMACEUTICALS, INC. logo
RCKT

ROCKET PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Aug 11, 2026
    Sale(S)
    Direct
    4.7K shares at avg. $3.50$16K
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    May 7, 2026
    Sale(S)
    Direct
    17.7K shares at avg. $3.84$68K
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Feb 11, 2026
    Award(A)
    Direct
    125.9K shares-

1-3 of 3

About Chaudhuri Sarbani

Chaudhuri Sarbani (SEC CIK 0002064940) files insider reports with the SEC as Officer of ROCKET PHARMACEUTICALS, INC. (RCKT).

Signal8 holds 4 ownership filings by Chaudhuri Sarbani (1 Form 3, 3 Form 4), filed between Apr 22, 2025 and Aug 13, 2026. Those filings report 3 transactions, from Feb 11, 2026 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chaudhuri Sarbani's filings is in CRANBURY, NJ.

Recent filings by Chaudhuri Sarbani

  • Aug 11, 2026: Open-market sale of RCKT shares (Form 4, code S).
  • May 7, 2026: Open-market sale of RCKT shares (Form 4, code S).
  • Feb 11, 2026: Grant or award of RCKT shares (Form 4, code A).

Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)

How to read Form 4 transaction codes